Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
group LV-Seoul National University Hospital refers to a specific treatment arm in a clinical trial conducted by Seoul National University Hospital investigating the blunting of hemodynamic responses during endotracheal intubation. In this protocol, a 10% lidocaine spray is applied topically to both the laryngoscope blade and the tracheal mucosa prior to intubation. Lidocaine is a local anesthetic that functions by blocking voltage-gated sodium channels, thereby inhibiting the conduction of nerve impulses from sensory neurons. By anesthetizing the airway and providing lubrication, this intervention aims to minimize the sympathetic surge (tachycardia and hypertension) associated with airway manipulation in neurosurgical patients undergoing anesthesia induction with propofol and remifentanil.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on group LV-Seoul National University Hospital.